ST Chang Medicine (300391.SZ): The company's stock may be delisted due to major violations of laws and regulations.

Zhitan Finance APP news, *ST Changyao (300391.SZ) issued an announcement, stating that the company received a "Notice" from the China Securities Regulatory Commission on December 26, 2025. According to the facts identified in the "Notice", the annual reports of the company in 2021, 2022, and 2023 contained false information. The company artificially increased operating income by 215.32 million yuan, 283.74 million yuan, and 233.63 million yuan in the annual reports from 2021 to 2023, accounting for 9.12%, 17.57%, and 19.51% of the disclosed operating income for the respective periods; the company also inflated the total profits by 56.40 million yuan, 63.38 million yuan, and 43.70 million yuan in the same period, accounting for 35.62%, 88.23%, and 6.42% of the absolute value of the disclosed total profits for the respective periods.